Log In
    ZOMDF
    $0.11
    (-2.61%)
    FLWS
    $4.14
    (-7.38%)
    ACCO
    $3.79
    (-1.3%)
    ARLP
    $23.3
    (-0.55%)
    AUIAF
    $0.11
    (-16.48%)
    AZZ
    $107.8
    (-0.12%)
    BTBT
    $2.23
    (10.4%)
    BTM
    $1.36
    (4.62%)
    CVKD
    $7.11
    (-3.53%)
    LCE:CA
    $0.29
    (1.72%)
    COCP
    $0.99
    (-1%)
    CDRO
    $7.98
    (5.98%)
    CVGI
    $1.53
    (0%)
    LODE
    $3.69
    (5.73%)
    CMTL
    $3.35
    (8.77%)
    CNDT
    $2.06
    (0.98%)
    CXW
    $18.97
    (-3.31%)
    CMLS
    $0.08
    (2.56%)
    DRCT
    $0.07
    (2.01%)
    DLHC
    $5.64
    (1.44%)
    SSP
    $4.7
    (-1.88%)
    ELDN
    $1.64
    (4.46%)
    EVC
    $3.18
    (0.63%)
    EDRY
    $13.06
    (-1.09%)
    ESEA
    $54.01
    (-0.09%)
    FAT
    $0.42
    (-3.68%)
    RAIL
    $9.06
    (-4.03%)
    GDEV
    $17.04
    (-4.7%)
    GOVX
    $0.16
    (-33.69%)
    GOCO
    $2.33
    (-9.69%)
    GHM
    $61.57
    (1.2%)
    GLDD
    $13.51
    (0.52%)
    GYRE
    $7.75
    (-1.27%)
    HMENF
    $1.42
    (-1.08%)
    III
    $5.92
    (-0.84%)
    IPOOF
    $8.75
    (-0.91%)
    KELYA
    $8.81
    (-2.87%)
    KTOS
    $75.39
    (5.59%)
    LUCK
    $9
    (-0.44%)
    MAIA
    $1.22
    (1.67%)
    MGROF
    $0.51
    (0.52%)
    NTRB
    $4.49
    (-0.88%)
    OCGN
    $1.4
    (-2.78%)
    PERF
    $1.81
    (2.26%)
    QMCI
    $0.15
    (0%)
    RGP
    $5.28
    (0.38%)
    SGA
    $11.35
    (0%)
    SHWZ
    $0
    (0%)
    SHIP
    $9.38
    (-2.09%)
    SLQT
    $1.33
    (-4.32%)
    SKYX
    $2.2
    (6.28%)
    SNAL
    $0.85
    (-4.54%)
    GEO
    $15.98
    (-3.33%)
    ODP
    $0
    (0%)
    TNXP
    $17.09
    (-6.15%)
    TSQ
    $5.3
    (0.57%)
    TZOO
    $7.18
    (-3.62%)
    UNCY
    $5.56
    (2.96%)
    VVX
    $53.48
    (0.45%)
    VNCE
    $4.03
    (13.36%)
    XELB
    $1.2
    (8.11%)
    ZOMDF
    $0.11
    (-2.61%)
    FLWS
    $4.14
    (-7.38%)

    channelchek-in

    ‌
    12/19/2025

    BioMarin to Acquire Amicus Therapeutics for $4.8 Billion, Expanding Leadership in Rare Diseases

    BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced it has entered into a definitive agreement to acquire Amicus Therapeutics (Nasdaq: FOLD) in an all-cash transaction valued at approximately $4.8 billion. Under the terms of the deal, BioMarin will acquire Amicus for $14.50 per share, representing a significant premium to Amicus’ recent trading levels. The transaction is expected to close in the second quarter of 2026, subject to regulatory approvals and Amicus shareholder approval.

    0
    3 min read
    • ‌
      Noble Capital Markets Research Morning Call

      Noble Capital Markets Research Morning Call

      Today’s Noble Capital Markets equity research reports, available with free...

      101 min read

    • Oracle Shares Surge as Cloud Giant Joins Investor Group to Run TikTok’s U.S. Business

      3 min read

    • Receive FREE Research, News, Video, and Event Updates in Your Inbox!

    • Trump Media Announces $6 Billion Fusion Merger With TAE Technologies as DJT Stock Surges

      3 min read
    View all

    News

    12/19/2025

    Release – GeoVax to Raise Approximately $3.2 Million of Gross Proceeds in Public Offering

    5 min read
    ‌
    Release – GeoVax to Raise Approximately $3.2 Million of Gross Proceeds in Public Offering
    12/19/2025

    BioMarin to Acquire Amicus Therapeutics for $4.8 Billion, Expanding Leadership in Rare Diseases

    3 min read
    ‌
    BioMarin to Acquire Amicus Therapeutics for $4.8 Billion, Expanding Leadership in Rare Diseases
    12/19/2025

    Greenwich LifeSciences, Inc. (GLSI) – FLAMINGO-01 Open-Label Arm Reports Preliminary Results and Reaches An Important Milestone

    2 min read
    ‌
    Greenwich LifeSciences, Inc. (GLSI) – FLAMINGO-01 Open-Label Arm Reports Preliminary Results and Reaches An Important Milestone
    12/19/2025

    Saga Communications (SGA) – A Shareholder First Centric Company

    3 min read
    ‌
    Saga Communications (SGA) – A Shareholder First Centric Company
    View all

    Research Reports

    Greenwich LifeSciences, Inc. (GLSI) – FLAMINGO-01 Open-Label Arm Reports Preliminary Results and Reaches An Important MilestoneGLI(Saga Communications (SGA) – A Shareholder First Centric CompanySC(Summit Midstream Corp (SMC) – A Multi-Year Reset Positions Summit for GrowthSMC(Tonix Pharmaceuticals (TNXP) – Tonix Acquires Another Pipeline Product For Neuropathic PainTP(
    View all

    Video Content

  • ‌
    Unicycive Therapeutics

    Unicycive Therapeutics

    Conference Presentation
    12/11/2025
  • ‌
    DataVault AI

    DataVault AI

    Conference Presentation
    12/5/2025
  • ‌
    NRX Pharma

    NRX Pharma

    Conference Presentation
    12/4/2025
  • ‌
    Nouveau Monde Graphite

    Nouveau Monde Graphite

    Conference Presentation
    12/4/2025
    • View all

    Movers

    Symbol
    Change
    NBY
    79.66%
    GDC
    51.59%
    SOS
    47.65%
    ASTI
    37.79%
    LUNR
    37.7%
    View all
    Log In